Evidence map›Paper›PMID 41630754›Full record

ArticleOpen veterinary journal2025

Exploring the antibacterial and anti-biofilm properties of

Mujahid Khalaf Ali, Hamad Sarheed Galut, Ezz El-Din Thabet Mahdi Matar, Shilan Farhad Mamand, Lana Sardar Sabrie, Shaymaa Farooq Mala, Muthana M Jghef

Abstract read
In one paragraph

Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Prevention and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  2. Disrupting Pathogenicity in FoodborneFoods (Basel, Switzerland) · 2026
    Article
  3. Tackling Drug Resistance and Virulence inThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mujahid Khalaf AliDepartment of Microbiology, College of Medicine, Tikrit University, Tikrit, Iraq.
Hamad Sarheed GalutDepartment of Radiology, College of Medical Technology, Al-Kitab University, Kirkuk, Iraq.
Ezz El-Din Thabet Mahdi MatarDepartment of Anatomy, College of Medicine, Tikrit University, Tikrit, Iraq.
Shilan Farhad MamandDepartment of Medical Microbiology, College of Science, Knowledge University, Erbil, Iraq.
Lana Sardar SabrieDepartment of Medical Microbiology, College of Science, Knowledge University, Erbil, Iraq.
Shaymaa Farooq MalaDepartment of Medical Laboratory Sciences, College of Science, Knowledge University, Erbil, Iraq.
Muthana M JghefDepartment of Anatomy, College of Medicine, Tikrit University, Tikrit, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial resistance (AMR), particularly methicillin-resistant Aim: This study aimed to investigate and compare the antibacterial and anti-biofilm effects of different Methods: Antibacterial efficacy was determined using the well-diffusion method, followed by the assessment of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against 10 MRSA strains. The antibiofilm potential was analyzed using a crystal violet assay. In addition, cytotoxicity was evaluated using an MTT assay on HCT-116 colorectal carcinoma cells. Results: Methanol demonstrated the highest antibacterial activity among the tested extracts. The MIC values ranged between 0.108 and 0.320 mg/ml, with corresponding MBC results confirming strong bactericidal effects. The anti-biofilm analysis indicated that the ethyl acetate extract exhibited the greatest inhibition of MRSA biofilm formation, followed by the dichloromethane and methanol extracts. Conclusion:

Indexed as

Anti-Bacterial AgentsBiofilmsMethicillin-Resistant Staphylococcus aureusPlant ExtractsRosmarinusHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsPlant ExtractsAntibacterialAntibiofilmAntibiotic resistanceMRSARosemary

Identifiers

PMID41630754
PMCPMC12861424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.